Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017192774> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2017192774 abstract "Objectives The aim of the study is to 1. observe the changes of circulating visfatin levels in patients with coronary heart disease (CHD), 2. and investigate the relationship between visfatin levels and the severity of CHD and coronary artery stenosis. Methods Participants and study design a total of 102 subjects were recruited from the first afflicted hospital of the university of South China, who underwent the coronary angiography (CAG) during 2010 to 2012. Based on CAG, the subjects were divided into following groups: non-CHD of 35 cases and CHD group of 67 cases. According to clinical presentation, ECG and the serological markers, CHD group was further classified into 2 subgroups: 28 cases of stable angina pectoris (SAP) group and 39 cases of acute myocardial infarction (AMI) group. According to the coronary artery lesion, all subjects can be divided into 4 groups: non-CHD group (35 cases), CHD single-vessel lesion group (26 cases), CHD double-vessel lesions group (20 cases), and CHD triple-vessel lesions group (21 cases). The quantitative assessment of the severity of coronary artery lesion was made in line with Gensini scores. The severity of coronary artery stenosis was assessed by the number of coronary artery lesion and the sum of the Gensini scores. According to the median level of visfatin ( M = 0.27 ng/mL), subjects can be divided into 2 groups: visfatin of A group is Assessments of plasma visfatin and serological index.The visfatin levels were determined by ELISA. HT, WT, BP, BMI were mesured. The levels of CK, CK-MB, cTnT, ESR, hs-CRP, TG, TC, LDL-C, HDL-C, and FPG were also detected. Statistical analysis Gensini score was calculated and the correlation between visfatin, serological markers and severity of coronary artery disease were analysed. The SPSS18.0 software was used for data analysis. Results There was statistically difference in visfatin levels between CHD group and non-CHD group [(0.41 ± 0.28) ng/ml vs. (0.20 ± 0.21) ng/ml ( P 0.05)]. The visfatin levels in AMI group were higher compared with SAP group [(0.47 ± 0.25) ng/mL vs. (0.33 ± 0.30) ng/mL, ( P P P The risk rate of suffering from AMI for patients with visfatin ≥ 0.27 ng/mL is 6.83 times as much as that for patients with visfatin The visfatin levels in CHD triple-vessel lesions group were higher than non-CHD group [(0.46 ± 0.30) vs.(0.20 ± 0.21) ng/ml, ( P P P The visfatin levels were positively correlated with TG ( r = 0.391, P r = 0.386, P r = 0.611, P r = 0.417, P r = 0.482, P r = -0.404, P F = 15.905, P Conclusions The visfatin levels are closely related with CHD. The visfatin levels may predict the severity of CHD. The visfatin levels exist positive correlation with the risk of AMI event occurence. hs-CRP and Gensini scores may be independent factors of visfatin." @default.
- W2017192774 created "2016-06-24" @default.
- W2017192774 creator A5009960780 @default.
- W2017192774 creator A5029827081 @default.
- W2017192774 creator A5030387223 @default.
- W2017192774 creator A5033633282 @default.
- W2017192774 creator A5040103549 @default.
- W2017192774 creator A5068815715 @default.
- W2017192774 creator A5077127165 @default.
- W2017192774 date "2013-08-01" @default.
- W2017192774 modified "2023-09-26" @default.
- W2017192774 title "GW24-e2520 Circulating visfatin levels and clinical significance in patients with coronary heart disease" @default.
- W2017192774 doi "https://doi.org/10.1136/heartjnl-2013-304613.422" @default.
- W2017192774 hasPublicationYear "2013" @default.
- W2017192774 type Work @default.
- W2017192774 sameAs 2017192774 @default.
- W2017192774 citedByCount "0" @default.
- W2017192774 crossrefType "journal-article" @default.
- W2017192774 hasAuthorship W2017192774A5009960780 @default.
- W2017192774 hasAuthorship W2017192774A5029827081 @default.
- W2017192774 hasAuthorship W2017192774A5030387223 @default.
- W2017192774 hasAuthorship W2017192774A5033633282 @default.
- W2017192774 hasAuthorship W2017192774A5040103549 @default.
- W2017192774 hasAuthorship W2017192774A5068815715 @default.
- W2017192774 hasAuthorship W2017192774A5077127165 @default.
- W2017192774 hasConcept C126322002 @default.
- W2017192774 hasConcept C141071460 @default.
- W2017192774 hasConcept C164705383 @default.
- W2017192774 hasConcept C2776820930 @default.
- W2017192774 hasConcept C2777785093 @default.
- W2017192774 hasConcept C2778213512 @default.
- W2017192774 hasConcept C2778425758 @default.
- W2017192774 hasConcept C2780007028 @default.
- W2017192774 hasConcept C2781156865 @default.
- W2017192774 hasConcept C3018906752 @default.
- W2017192774 hasConcept C3019004856 @default.
- W2017192774 hasConcept C500558357 @default.
- W2017192774 hasConcept C71924100 @default.
- W2017192774 hasConceptScore W2017192774C126322002 @default.
- W2017192774 hasConceptScore W2017192774C141071460 @default.
- W2017192774 hasConceptScore W2017192774C164705383 @default.
- W2017192774 hasConceptScore W2017192774C2776820930 @default.
- W2017192774 hasConceptScore W2017192774C2777785093 @default.
- W2017192774 hasConceptScore W2017192774C2778213512 @default.
- W2017192774 hasConceptScore W2017192774C2778425758 @default.
- W2017192774 hasConceptScore W2017192774C2780007028 @default.
- W2017192774 hasConceptScore W2017192774C2781156865 @default.
- W2017192774 hasConceptScore W2017192774C3018906752 @default.
- W2017192774 hasConceptScore W2017192774C3019004856 @default.
- W2017192774 hasConceptScore W2017192774C500558357 @default.
- W2017192774 hasConceptScore W2017192774C71924100 @default.
- W2017192774 hasLocation W20171927741 @default.
- W2017192774 hasOpenAccess W2017192774 @default.
- W2017192774 hasPrimaryLocation W20171927741 @default.
- W2017192774 hasRelatedWork W1642176912 @default.
- W2017192774 hasRelatedWork W1902158614 @default.
- W2017192774 hasRelatedWork W1983760971 @default.
- W2017192774 hasRelatedWork W1991430195 @default.
- W2017192774 hasRelatedWork W1994752417 @default.
- W2017192774 hasRelatedWork W1998647058 @default.
- W2017192774 hasRelatedWork W2057665026 @default.
- W2017192774 hasRelatedWork W2066732880 @default.
- W2017192774 hasRelatedWork W2067981934 @default.
- W2017192774 hasRelatedWork W2137028587 @default.
- W2017192774 hasRelatedWork W2150744269 @default.
- W2017192774 hasRelatedWork W2317354376 @default.
- W2017192774 hasRelatedWork W2319517181 @default.
- W2017192774 hasRelatedWork W2356444265 @default.
- W2017192774 hasRelatedWork W2357836117 @default.
- W2017192774 hasRelatedWork W2408894554 @default.
- W2017192774 hasRelatedWork W2417961714 @default.
- W2017192774 hasRelatedWork W2656095334 @default.
- W2017192774 hasRelatedWork W2990726481 @default.
- W2017192774 hasRelatedWork W2594288977 @default.
- W2017192774 isParatext "false" @default.
- W2017192774 isRetracted "false" @default.
- W2017192774 magId "2017192774" @default.
- W2017192774 workType "article" @default.